All News

TACTI-004 follows 2 clinical trials, TACTI-002 and INSIGHT-003, which also assessed efti with pembrolizumab in first-line treatment of non–small cell lung cancer (NSCLC).

Patients must fight to be heard; health care providers are uniquely positioned to listen.

The approved indication now includes adults with moderately to severely active ulcerative colitis and Crohn disease who have not been treated with tumor necrosis factor blocking agents.

The move emphasizes the need for vigilant monitoring.

Bariatric vitamins ensure nutrient absorption for optimal recovery and health post surgery.

Higher levels of cyclic adenosine monophosphate (cAMP) may be key to diagnosing asthma and its severity as well as monitoring patients.

The ratio of high-density lipoprotein cholesterol (HDL-C) to low-density lipoprotein cholesterol (LDL-C) can predict cardiovascular disease (CVD) risk in patients with and without diabetes.

CDC layoffs threaten public health surveillance, prompting urgent reinstatement of staff as pharmacists face challenges in community health response.

Each month, Timothy Ulbrich will share lessons on mindset, strategy, and habits to help pharmacists achieve lasting security and financial freedom.

Awareness, early identification, and proper management are critical to mitigate associated risks.

Inhaled insulin Afrezza offers a rapid-acting alternative for children with type 1 diabetes, enhancing blood glucose control and patient satisfaction.

Pharmacists’ medication expertise strengthens clinical care and supports a more collaborative, team-based approach to patient health.

The integration of artificial intelligence into health care represents a shift in how pharmacists approach medication management and patient care.

Believe it or not, none of them are pharmacy specific.

FDA approves Uzedy, an extended-release injectable formulation of risperidone, enhancing treatment options for adults with bipolar I disorder.

Invasive lobular carcinoma poses unique detection and treatment challenges, highlighting the urgent need for targeted research and improved survival strategies.

The pharmaceutical giant will reportedly lower its drug prices to align with most-favored-nation status.

Public debate intensifies as Robert F. Kennedy Jr compares selective serotonin reuptake inhibitors (SSRIs) to heroin, prompting mental health experts to clarify antidepressant use and withdrawal misconceptions.

A hybrid chatbot that evaluates stages of change in pneumococcal vaccination desires while providing artificial intelligence (AI)-based Q&A opportunities improved uptake in older adults.

The FDA approves Eydenzelt, a biosimilar for retinal diseases, enhancing treatment options for diabetic macular edema and age-related macular degeneration.

Researchers highlight the critical link between school vaccination rates and measles outbreaks, urging targeted public health strategies to combat misinformation and improve MMR coverage.

Discover groundbreaking FDA approvals for innovative treatments, including semaglutide for liver health and bumetanide nasal spray for heart failure.

Explore recent FDA-approved drugs from September 2025.

Combining tramadol with CYP2D6-inhibiting antidepressants raises seizure risk in older adults, highlighting the need for careful medication management.

Ron Lanton advises pharmacies to maintain compliance, explore contingency options, and stay engaged with policymakers during the government shutdown.

Repetitive DNA mimics pathogens, influencing cancer immunity and immunotherapy.